Apoptotic effect of imatinib on human colon adenocarcinoma cells: Influence on actin cytoskeleton organization and cell migration

European Journal of Pharmacology

Volumn 667, Issue 1-3, 2011, Pages 66-73

  Popow Woźniak, Agnieszka ^a   Woźniakowska, Aleksandra ^a   Kaczmarek, Łukasz ^b   Malicka Błaszkiewicz, Maria ^a   Nowak, Dorota ^a  

^a UNIVERSITY OF WROC AW   (Poland)

^b INDUSTRIAL CHEMISTRY RESEARCH INSTITUTE   (Poland)

Author keywords

Actin cytoskeleton; Apoptosis; Imatinib; Migration

Indexed keywords

ACTIN; CASPASE 3; IMATINIB; PHOSPHATIDYLSERINE;

ACTIN POLYMERIZATION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; COLON ADENOCARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOARCHITECTURE; CYTOSKELETON; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MEMBRANE LEAFLET; MIGRATION INHIBITION; PHOSPHOLIPID TRANSFER; PRIORITY JOURNAL;

ACTINS; ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; CYTOSKELETON; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PIPERAZINES; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES;

EID: 80052021604     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.05.036     Document Type: Article

References (51)

1. T.J. Abouantoun, and T.J. MacDonald Imatinib blocks migration and invasion medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor Mol. Cancer Ther. 8 2009 1137 1147
2. S. Ali, and S. Ali Role of c-kit/SCF in cause and treatment of gastrointestinal tumors (GIST) Gene 401 1-2 2007 38 45 (Pubitemid 47379512)
3. S. Attoub, C. Rivat, S. Rodrigues, S. Van Bocxlaer, M. Bedin, E. Bruyneel, C. Louvet, M. Kornprobst, T. André, M. Mareel, J. Mester, and C. Gespach The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy Cancer Res. 62 17 2002 4879 4883 (Pubitemid 34984407)
4. G. Bellone, A. Carbone, N. Sibona, O. Bosco, D. Tibaudi, C. Smirne, T. Martone, C. Gramigni, M. Camandona, G. Emanuelli, and U. Rodeck Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential Cancer Res. 61 5 2001 2200 2206 (Pubitemid 32692048)
5. G. Bellone, D. Ferrero, A. Carbone, M.R. De Quadros, C. Gramigni, A. Prati, W. Davidson, P. Mioli, L. Dughera, G. Emanuelli, and U. Rodeck Inhibition of cell survival and invasive potential of colorectal carcinoma cells by the tyrosine kinase inhibitor STI571 Cancer Biol. Ther. 3 4 2004 385 392 (Pubitemid 41350868)
6. R. Bertrand, E. Solary, P. O'Connor, K.W. Kohn, and Y. Pommier Induction of a common pathway of apoptosis by staurosporine Exp. Cell Res. 211 1994 314 321 (Pubitemid 24174963)
7. S.K. Biswas, Y. Zhao, and L. Sandirasegarane Imatinib induced apoptosis by inhibiting PDGF - but not insulin - induced PI3-kinase/Akt survival signaling in RGC-5 retinal ganglion cells Mol. Vision. 15 2009 1599 1610
8. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing, the principle of protein-dye binding Anal. Biochem. 272 1976 248 254
9. K.F. Croom, and C.M. Perry Imatinib mesylate: in the treatment of gastrointestinal stromal tumours Drugs 63 2003 513 524
10. D. Cunningham, W. Atkin, H. Lenz, H. Lynch, B. Minsky, B. Nordlinger, and N. Starling Colorectal cancer Lancet 375 2010 1030 1047
11. P. de Mestier, and G. des Guetz Treatment of gastrointestinal stromal tumors with imatinib mesylate: a major breakthrough in the understanding of tumor-specific molecular characteristics World J. Surg. 3 2005 357 3561
12. B. Druker Imatinib (Imatinib mesylate) as a paradigm of targeted cancer therapies Keio J. Med. 59 1 2010 1 3
13. + leukemic cells and induces apoptosis Blood Cells Mol. Dis. 23 1997 380 394 (Pubitemid 28123720)
14. J.M. Goldman Imatinib Drugs 61 12 2001 1775 1776
15. P.M. Gordon, and D.E. Fisher Role for the proapoptotic factor BIM in mediating imatinib-induced apoptosis in c-kit-dependent gastrointestinal stromal tumor cell line J. Biol. Chem. 285 2010 14109 14114
16. C.W. Gourlay, and K.R. Ayscough The actin cytoskeleton in ageing and apoptosis FEMS Yeast Res. 5 2005 1193 1198 (Pubitemid 41607740)
17. C. Hayot, O. Debeir, P. Van Ham, M. Van Damme, R. Kiss, and C. Decaestecker Characterization of the activities of actin-affecting drugs on tumor cell migration Toxicol. Apll Pharmacol. 211 2006 30 40 (Pubitemid 43152095)
18. S. Holdenrieder, and P. Stieber Apoptotic markers in cancer Clin. Biochem. 37 2004 605 617 (Pubitemid 38845023)
19. R.F. Hwang, K. Yokoi, C.D. Bucana, R. Tsan, J.J. Killion, D.B. Evans, and I.J. Fidler Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Imatinib mesylate) reduced growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model Clin. Cancer Res. 9 2003 6534 6544 (Pubitemid 38031842)
20. M.A. Jordan, and L. Wilson Microtubules and actin filaments: dynamic target for cancer chemotherapy Curr. Opin. Cell Biol. 10 1998 123 130 (Pubitemid 28066130)
21. C. Kieda, M. Paprocka, A. Krawczenko, P. Załȩcki, P. Dupuis, M. Monsigny, C. Radzikowski, and D. Duś New human microvascular endothelial cell lines with specific adhesion molecules phenotypes Endothelium 9 2002 247 261 (Pubitemid 36040397)
22. M. Kruidering, B. van de Water, Y. Zhan, J.J. Baelde, E. de Heer, G.J. Mulder, J.L. Stevens, and J.F. Nagelkerke Cisplatin effect on F-actin and matrix proteins precede renal tubular cell detachment and apoptosis in vitro Cell Death Differ. 5 1998 601 614 (Pubitemid 28356582)
23. T. Kubota Gastrointestinal stromal tumor (GIST) and imatinib Int. J. Clin. Oncol. 11 3 2006 184 189 (Pubitemid 44087116)
24. T. Kurosu, N. Wu, G. Oshikawa, H. Kagechika, and O. Miura Enhancement of imatinib-induced apoptosis of BCR/ABL-expressing cells by nutlin-3 through synergistic activation of mitochondrial apoptotic pathway Apoptosis 15 2010 608 620
25. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
26. A. Lemmnon, and J. Schlessinger Cell signaling by receptor kinases Cell 141 2010 1117 1134
27. M. Malicka-Błaszkiewicz, and J.S. Roth Some factors affecting the interaction between actin in leukemia L1210 cells and DNase I Biochem. Biophys. Res. Commun. 102 1981 549 601
28. T. Mashima, M. Naito, and T. Tsuruo Caspase-mediated cleavage of cytoskeletal actin plays a positive role in the process of morphological apoptosis Oncogene 18 1999 2423 2430 (Pubitemid 29206155)
29. A. Mazur, D. Nowak, H.G. Mannherz, and M. Malicka-Błaszkiewicz Apoptotic effect of methotexate on CaSki and NRK cells - influence on actin cytoskeleton organization Eur. J. Pharmacol. 613 2009 24 33
30. J.C. Mills, N.L. Sone, and R.N. Pittman Extranuclear apoptosis: the role of the cytoplasm in the execution phase J. Cell Biol. 146 1999 703 707 (Pubitemid 29408897)
31. D. Nowak, A. Krawczenko, D. Duś, and M. Malicka- Błaszkiewicz Actin in human colon adenocarcinoma cells with different metastatic potential Acta Biochim. Polon. 4 2002 823 828 (Pubitemid 135702934)
32. D. Nowak, A. Skwarek-Maruszewska, M. Zemanek-Zboch, and M. Malicka-Błaszkiewicz Beta actin in human colon adenocarcinoma cells with different metastatic potential Acta Biochim. Polon. 52 2005 461 468 (Pubitemid 41133782)
33. D. Nowak, A. Mazur, A. Popow-Woźniak, A. Radwańska, H.G. Mannherz, and M. Malicka-Błaszkiewicz Subcellular distribution and expression of cofilin and ezrin in human colon adenocarcinoma cell lines with different metastatic potential Eur. J. Histochem. 54 2 2010 59 66
34. C. Odaka, M.L. Sanders, and P. Crews Jasplakinolide induces apoptosis in various transformed cell lines by a caspase-3-like protease-dependent pathway Clin. Diagn. Lab. Immunol. 7 2000 947 952 (Pubitemid 32244495)
35. R. Ohno Treatment of chronic myeloid leukemia with imatinib mesylate Int. J. Clin. Oncol. 11 3 2006 176 183 (Pubitemid 44087115)
36. A. Opolski, J. Wietrzyk, D. Duś, C. Kieda, A. Matejuk, A. Makowska, E. Wojdat, M. Ugorski, A. Laskowska, A. Kłopocki, J. Rygaard, and C. Radzikowski Metastatic potential and saccharide antigens expression of human colon cancer cells xenotransplanted into athymic nude mice Folia Microbiol. 43 1998 507 510 (Pubitemid 128439393)
37. S. Rakshit, J. Bagchi, L. Mandal, K. Paul, D. Ganguly, S. Bhattacharjee, M. Ghosh, N. Biswas, U. Chaudhuri, and S. Bandyopadhyay N-acetyl cysteine enhances imatinib-induced apoptosis of Bcr-Abl + cells by endothelial nitric oxide synthase-mediated production of nitric oxide Apoptosis 14 3 2009 298 308
38. E. Ranza, G. Mazzini, A. Facoetti, and R. Nano In vitro effects of tyrosine kinase inhibitor imatinib on glioblastoma cell proliferation J. Neurooncol 96 2010 349 357
39. J.Y. Rao, and N. Li Microfilament actin remodelling as a potential target for cancer drug development Curr. Cancer Drug Targets 4 2004 267 283
40. M. Rosenblum, and R. Shivers Rings of F-actin form around the nucleus in cultured human MCF7 adenocarcinoma cells upon exposure to both taxol and taxot Comp. Biochem. Physiol. 125 2000 121 131 (Pubitemid 30204591)
41. A. Saraste, and K. Pulkki Morphologic and biochemical hallmarks of apoptosis Cardiovasc. Res. 45 2000 528 537 (Pubitemid 30047119)
42. D.G. Savage, and K.H. Antman Imatinib mesylate-a new oral targeted therapy N. Engl. J. Med. 346 9 2002 683 693 (Pubitemid 34815874)
43. A. Sawaki, and K. Yamao Imatinib mesylate acts in metastatic or unresectable gastrointestinal stromal tumor by targeting KIT receptors-a review Cancer Chemother. Pharmacol. 54 2004 44 49
44. J.T. Sims, and R. Plattner MTT assays cannot be utilized to study the effects of STI571/Imatinib mesylate on the viability of solid tumor cell lines Cancer Chemother. Pharmacol. 64 3 2009 629 633
45. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J.T. Warren, H. Bokesch, S. Kenney, and M.R. Boyd New colorimetric cytotoxicity assay for anticancer-drug screening J. Natl. Cancer Inst. 82 1990 1107 1112 (Pubitemid 20213250)
46. Szczepek, W., Samson-Łazińska, D., Zagrodzki, B., Glice, M., Maruszak, W., Korczak, K., Modzelewski, R., Ławecka, M., Kaczmarek, Ł., Szelejewski, W., Fra̧czek, U., Cmoch, P., 2010. Crystalline Polymorphs of Methanesulfonic acid addition salts of imatinib, patent US 7,732,601 B2.
47. M. Tardieu, J. Domont, A. Cioffi, S. Bonvalot, and A. Le Cesne Focus on GIST management Bull. Cancer 97 2010 723 731
48. H. Towbin, T. Stachelin, and T. Gordon Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications Proc. Natl. Acad. Sci. USA 76 1979 466 472
49. T. Utsumi, N. Sakurai, K. Nakano, and R. Ishisaka C-terminal 15-kDa fragment of cytoskeletal actin is posttranslationally N-myristoylated upon caspase-mediated cleavage and targeted to mitochondria FEBS Lett. 539 2003 37 44 (Pubitemid 36351284)
50. C.F. Waller Imatinib mesylate Recent Results Cancer Res. 184 2010 3 20
51. A.H. Wyllie Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview Cancer Metastasis Rev. 11 1992 95 103